SAN CARLOS, Calif., May 24 /PRNewswire-FirstCall/ -- Nuvelo, Inc. today announced that it will participate in the following events in June:
Bank of America 2007 Health Care Conference June 1, 2007 9:20 a.m. PT Dr. Ted W. Love, Chairman and CEO http://www.veracast.com/webcasts/bas/healthcare07/id43308652.cfm The Sixth Annual Needham & Company, LLC Biotechnology & Medical Technology Conference June 13, 2007 9:00 a.m. ET Dr. Michael Levy, EVP, Research and Development http://www.wsw.com/webcast/needham18/nuvo/
Live audio webcasts of the events and presentations will also be available online via the Investor Relations portion of Nuvelo’s website at http://www.nuvelo.com.
About Nuvelo
Nuvelo, Inc. is dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular and cancer therapy. Nuvelo’s development pipeline includes three acute cardiovascular programs: alfimeprase, a direct-acting thrombolytic for the treatment of thrombotic-related disorders; rNAPc2, an anticoagulant that inhibits the factor VIIa and tissue factor protease complex that completed Phase 2 clinical development in acute coronary syndromes; and preclinical candidate NU172, a direct thrombin inhibitor for use as a short-acting anticoagulant during medical or surgical procedures. Nuvelo is also advancing an emerging oncology pipeline, including rNAPc2, which is in Phase 2 testing for potential use as a cancer therapy, as well as NU206 for the potential treatment of chemotherapy/radiation therapy-induced mucositis and inflammatory bowel disease. In addition, Nuvelo expects to leverage its expertise in secreted proteins and cancer antibody discovery to further expand its pipeline and create additional partnering and licensing opportunities.
Information about Nuvelo is available at our website at http://www.nuvelo.com or by phoning 650-517-8000.
Nuvelo, Inc.
CONTACT: Nicole Foderaro, Director, Corporate Communications & IR ofNuvelo, Inc., +1-650-517-8472, nfoderaro@nuvelo.com
Web site: http://www.nuvelo.com//
